Document Detail


Future therapies for food allergy.
MedLine Citation:
PMID:  22894951     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Food allergy affects 3.9% of US children and is increasing in prevalence. The current standard of care involves avoidance of the triggering food and treatment for accidental ingestions. While there is no current curative treatment, there are a number of therapeutic strategies under investigation. Allergen specific therapies include oral and sublingual immunotherapy with native food protein as well as recombinant food proteins. Allergen non-specific therapies include a Chinese herbal formula (FAHF-2) and the use of anti-IgE monoclonal antibody therapy. Although none of these treatments are ready for clinical use, these therapeutic strategies present promising options for the future of food allergy.
Authors:
Laurie M McWilliams; Talal Mousallem; A Wesley Burks
Publication Detail:
Type:  Journal Article; Review     Date:  2012-08-16
Journal Detail:
Title:  Human vaccines & immunotherapeutics     Volume:  8     ISSN:  2164-554X     ISO Abbreviation:  Hum Vaccin Immunother     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2013-03-20     Completed Date:  2013-09-11     Revised Date:  2014-10-09    
Medline Journal Info:
Nlm Unique ID:  101572652     Medline TA:  Hum Vaccin Immunother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1479-84     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Food Hypersensitivity / drug therapy,  immunology,  therapy*
Humans
Immunotherapy / methods*
Grant Support
ID/Acronym/Agency:
T32 AI007062/AI/NIAID NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Tetanus toxoid vaccine: elimination of neonatal tetanus in selected states of India.
Next Document:  House dust allergy and immunotherapy.